Chagas' sjukdom i sverige - stort behov av riktlinjer för testning

Lakartidningen

Volumn 108, Issue 46, 2011, Pages 2368-2371

  Sandahl, Katarina ^a   Botero Kleiven, Silvia ^b   Hellgren, Urban ^c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Smittskyddsinstitutet ^*  (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PROTOZOON ANTIBODY;

BLOOD; CHAGAS DISEASE; DISEASE TRANSMISSION; EUROPE; FEMALE; HEALTH; HUMAN; IMMUNOLOGY; MALE; MASS SCREENING; MIGRATION; NOTE; PRACTICE GUIDELINE; PREGNANCY; SOUTH AMERICA; SWEDEN; TRYPANOSOMA CRUZI;

ANTIBODIES, PROTOZOAN; CHAGAS DISEASE; EMIGRATION AND IMMIGRATION; EUROPE; FEMALE; HUMANS; MALE; MASS SCREENING; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; SOUTH AMERICA; SWEDEN; TRYPANOSOMA CRUZI; WORLD HEALTH;

EID: 82355163310     PISSN: 00237205     EISSN: 16527518     Source Type: Journal    
DOI: None     Document Type: Note

References (14)

1. Chagas disease: control and elimination. Report for 63:d World Health Assembly. 2010. WHO. Report nr A63/17. http://apps.who.int/gb/ebwha/pdf_files/WHA63/A63_17-en.pdf
2. Control and prevention of Chagas disease in Europe. Geneva, Switzerland 2010. WHO. Report nr WHO/HTM/NTD/IDM/2010.1. http://www.fac.org.ar/1/comites/chagas/Chagas_WHO_Technical% 20Report_16_06_10.pdf
3. Prata A. Clinical and epidemiological aspects of Chagas disease. Lancet Infect Dis. 2001;1(2):92-100
4. Rassi A Jr, Rassi A, Marin-Neto JA. Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification. Mem Inst Oswaldo Cruz. 2009; 104 Suppl 1:152-8
5. Schmunis GA. Epidemiology of Chagas disease in non-endemic countries: the role of international migration. Mem Inst Oswaldo Cruz. 2007;102 Suppl 1:75-85
6. Riarte A, Luna C, Sabatiello R, Sinagra A, Schiavelli R, De Rissio A, et al. Chagas' disease in patients with kidney transplants: 7 years of experience 1989-1996. Clin Infect Dis. 1999;29(3):561-7
7. Schijman A, Altcheh J, Burgos J, Biancardi M, Bisio M, Levin M, et al. Aetiological treatment of congenital Chagas' disease diagnosed and monitored by the polymerase chain reaction. J Antimicrob Chemother. 2003;52(3):441-9
8. Otani MM, Vinelli E, Kirchhoff LV, del Pozo A, Sands A, Vercauteren G, et al. WHO comparative evaluation of serologic assays for Chagas disease. Transfusion. 2009;49(6):1076-82
9. Bronner U, Botero-Kleiven S, Claesson B. Riktlinjer för diagnostik av Chagas sjukdom orsakad av Trypanosoma cruzi. Svenska Läkaresällskapets referensgrupp för parasitologi; 2009. http://parasitologi.se/index.php/riktlinjer_och_rekommendationer/urdjur__protozoer_/trypanosoma_cruzi
10. Viotti R, Vigliano C, Lococo B, Bertocchi G, Petti M, Alvarez M, et al. Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial. Ann Intern Med. 2006;144(10): 724-34
11. Rassi A, Marin-Neto JA. Chagas disease. Lancet. 2010;375(9723): 1388-402
12. Jannin J, Salvatella R. Estimacion cuantitativa de la enfermedad de Chagas en las Americas. Montevideo, Uruguay: PAHO. Department for Neglected tropical Diseases and Innovative and Intensified Disease Management; 2006. p. 28. Report nr: OPS/HDM/CD405-06
13. Jackson Y, Gétaz L, Wolff H, Holst M, Mauris A, Tardin A, et al. Prevalence, clinical staging and risk for blood-borne transmission of Chagas disease among Latin American migrants in Geneva, Switzerland. PLoS Negl Trop Dis. 2010;4(2):e592.
14. Muñoz J, Coll O, Juncosa T, Vergés M, del Pino M, Fumado V, et al. Prevalence and vertical transmission of Trypanosoma cruzi infection among pregnant Latin American women attending 2 maternity clinics in Barcelona, Spain. Clin Infect Dis. 2009;48(12):1736-40